Evidence map›Paper›PMID 39768087›Full record

ArticleBioengineering (Basel, Switzerland)2024

Temporal Tissue Remodeling in Volumetric Muscle Injury with Endothelial Cell-Laden Patterned Nanofibrillar Constructs.

Krista M Habing, Cynthia A Alcazar, Nathaniel Dobson, Yong How Tan, Ngan F Huang, Karina H Nakayama

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Krista M HabingDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0003-2735-9980
Cynthia A AlcazarDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0009-0003-7336-5895
Nathaniel DobsonDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.
Yong How TanDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.
Ngan F HuangDepartment of Cardiothoracic Surgery, Stanford University, Palo Alto, CA 94304, USA.ORCID 0000-0003-2298-6790
Karina H NakayamaDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.

Funding

Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
Regenerative engineering for complex extremity traumaR01AR080150 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Karina Nakayama · 2023 to 2026
$2.1M
Development of a Bioengineered Therapeutic Device for the Prevention of LymphedemaR01CA285372 · NCI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI Ngan F. Huang, Michael Vitoldovich Paukshto · 2024 to 2026
$1.6M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
Spatial patterning modulates tissue revascularization and regenerationR00HL136701 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NAKAYAMA, KARINA · 2020 to 2022
$741k
Biomaterials for delivery and maintenance of tip endothelial cellsR21HL172096 · NHLBI · UNIVERSITY OF CALIFORNIA, MERCED · PI HUANG, NGAN F., MCCLOSKEY, KARA E · 2024 to 2025
$643k
Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery DiseaseR41HL170875 · NHLBI · SERINA THERAPEUTICS, INC. · PI HUANG, NGAN F., LEE, JI EUN · 2023 to 2023
$341k
BLRD VA I01 BX004259BLRD VA I01 BX006955BLRD VA IK6 BX006309National Science Foundation DGE-1937961NCATS NIH HHS TL1 TR002371NCI NIH HHS R01 CA285372NHLBI NIH HHS R00 HL136701NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R21 HL172096NHLBI NIH HHS R41 HL170875NIAMS NIH HHS R01 AR080150NIH/NHLBI R21 HL172096-01Oregon Students Learn and Experience Research Program TL1TR002371RRD VA I01 RX001222RRD VA I21 RX004898US Department of Veterans Affairs 1I01BX004259US Department of Veterans Affairs 1I21RX004898US Department of Veterans Affairs 5I01RX001222VA IK6 BX006309
6 · The paper itself

Abstract

A primary challenge following severe musculoskeletal trauma is incomplete muscle regeneration. Current therapies often fail to heal damaged muscle due to dysregulated healing programs and insufficient revascularization early in the repair process. There is a limited understanding of the temporal changes that occur during the early stages of muscle remodeling in response to engineered therapies. Previous work demonstrated that nanotopographically patterned scaffolds provide cytoskeletal guidance and direct endothelial angiogenic and anti-inflammatory phenotypes. The aim of this study was to evaluate how endothelial cell (EC) patterning guides temporal and histomorphological muscle remodeling after muscle injury. In the current study, mice were treated with EC-laden engineered constructs that exhibited either aligned or random patterning of collagen nanofibrils, following a volumetric muscle loss injury (VML). Remodeling was evaluated at 2, 7, and 21 days post injury. Over the 21-day study, all groups (Acellular Aligned, EC Aligned, EC Random) demonstrated similar significant increases in vascular density and myogenesis. Animals treated with acellular controls demonstrated a two-fold decrease in muscle cross-sectional area between days 2 and 21 post injury, consistent with VML-induced muscle atrophy; however, animals treated with patterned EC-laden constructs exhibited preservation of muscle mass. The implantation of an EC-laden construct led to a 50% increase in the number of animals exhibiting areas of fibrous remodeling adjacent to the construct, along with greater collagen deposition (

Indexed as

collagen scaffoldendothelial cell patterningmusculoskeletal traumaregenerationtemporal remodelingvolumetric muscle loss

Identifiers

PMID39768087
PMCPMC11673213

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.